Clinical study of tirofiban compared to low molecular weight heparin in the antithrombotic treatment of progressive pontine infarction
CONCLUSIONS: Tirofiban may be more effective and safer than LMWH in controlling the progression of acute pontine infarction, but further and large-sample studies are still needed to confirm this finding.PMID:38567581 | DOI:10.26355/eurrev_202403_35722
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Q Zhou L-E Xu L-L Lin X-R Huang W-Z Chi J Lin P Lin Source Type: research
More News: Aspirin | Bleeding | Brain | Clopidogrel | Drugs & Pharmacology | Neurology | Plavix | Statistics | Stroke | Study